Walleye Capital’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Walleye Capital's ALT Position: Q3 2026 in Review
Walleye Capital reduced its Altimmune (ALT) stake by 100% in Q3 2026, selling an estimated $26.1K and leaving 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #5912.
Walleye Capital first reported a position in ALT in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.58M in Q2 2022. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Walleye Capital held 2 shares of Altimmune worth $6 as of Q3 2026.
- Walleye Capital sold 8,497 Altimmune shares in Q3 2026, an estimated $26.1K.
- Altimmune made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5912 holding.
- Walleye Capital first reported a position in Altimmune in Q4 2021 and has held it in 14 quarters since.
- Walleye Capital's Altimmune position peaked at $1.58M in Q2 2022.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.